“Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?”

array:24 ["pii" => "S1665268119300742" "issn" => "16652681" "doi" => "10.1016/j.aohep.2019.01.011" "estado" => "S300" "fechaPublicacion" => "2019-09-01" "aid" => "66" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2019" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2019;18:765-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 401 "formatos" => array:3 [ "EPUB" => 24 "HTML" => 164 "PDF" => 213 ] ] "itemSiguiente" => array:18 [ "pii" => "S1665268119300602" "issn" => "16652681" "doi" => "10.1016/j.aohep.2019.01.008" "estado" => "S300" "fechaPublicacion" => "2019-09-01" "aid" => "52" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2019;18:770-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 264 "formatos" => array:3 [ "EPUB" => 21 "HTML" => 151 "PDF" => 92 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Original articles" "titulo" => "Protective effects of mild hypothermia against hepatic injury in rats with acute liver failure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "770" "paginaFinal" => "776" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2690 "Ancho" => 2915 "Tamanyo" => 784852 ] ] "descripcion" => array:1 [ "en" => "Effects of mild hypothermia on HMGB1 levels in blood and hepatic tissues (A) and (B) serum HMGB1 levels determined by ELISA and mRNA levels of HMGB1 in hepatic tissues detected by RT-PCR. (C) Agarose gel electrophoresis images of HMGB1 mRNA expression in hepatic tissue. (D) Representative images of protein expression levels of HMGB1 in hepatic tissue, detected by immunohistochemistry at 400× magnification. (E) Protein expression levels of HMGB1 in hepatic tissue, indicated by immunohistochemistry staining scores. β-Actin was used as a control. ***P<0.001 vs. CG; **P<0.01 vs. CG; *P<0.05 vs. CG; ###P<0.001 vs. NG; ##P<0.01 vs. NG; #P<0.05 vs. NG. HMGB1, high mobility group box 1; ELISA, enzyme-linked immunosorbent assay; mRNA, messenger ribonucleic acid; RT-PCR, reverse transcription-polymerase chain reaction; CG, control group; NG, normothermia group; MHG, mild hypothermia group." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ying Zhu, Tianxin Xiang, Dali Hu, Bairu Shi, Wenyuan Zhang, Shouhua Zhang, Xiaoping Wu" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Ying" "apellidos" => "Zhu" ] 1 => array:2 [ "nombre" => "Tianxin" "apellidos" => "Xiang" ] 2 => array:2 [ "nombre" => "Dali" "apellidos" => "Hu" ] 3 => array:2 [ "nombre" => "Bairu" "apellidos" => "Shi" ] 4 => array:2 [ "nombre" => "Wenyuan" "apellidos" => "Zhang" ] 5 => array:2 [ "nombre" => "Shouhua" "apellidos" => "Zhang" ] 6 => array:2 [ "nombre" => "Xiaoping" "apellidos" => "Wu" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119300602?idApp=UINPBA00004N" "url" => "/16652681/0000001800000005/v2_201909050846/S1665268119300602/v2_201909050846/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1665268119300730" "issn" => "16652681" "doi" => "10.1016/j.aohep.2019.03.007" "estado" => "S300" "fechaPublicacion" => "2019-09-01" "aid" => "65" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "pgl" "cita" => "Ann Hepatol. 2019;18:757-64" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 216 "formatos" => array:3 [ "EPUB" => 16 "HTML" => 129 "PDF" => 71 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "HIF1a Inhibitor Rescues Acute-on-Chronic Liver Failure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "757" "paginaFinal" => "764" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2087 "Ancho" => 3015 "Tamanyo" => 430733 ] ] "descripcion" => array:1 [ "en" => "Effects of genistein on mitochondrial function and ROS production.Mitochondrialwas isolated from rat hepatocytes. Liver tissues were cut into pieces to obtain single cells using the single-cell suspension preparation equipment The suspension was centrifuged at 4000g for 10min at 4°C. The single-cell precipitate was resuspended. ROS fluorescent probe 2’, 7’-dichlorofluorescin diacetate was added and fluorescence intensity of single cell suspension was measured at random using flow cytometry. Different correspondence letters indicate significant differences at P<0.05 by the Student t test.* p <0.05, ** p <0.001. ATP content in mitochondriain GroupI, II, III and IV. (B) ADP/O level in GroupI, II, III and IV. (C)Mitochondrial respiratory control ratio (RCR) in GroupI, II, III and IV. (D) The detection of MPTP opening in GroupI, II, III and IV.(E) The ultrastructure of mitochondria in GroupI, II, III and IV. (F-J)ROS level in GroupI, II, III, IV and V (K-M) MTPT, ATP content and RCR of mitochondrial in Group III, IV and V.(N-P) ATP content, RCR and MTPT of mitochondrial in, Group III, IV and VI." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Fang Xie, Jinling Dong, Yueke Zhu, Kefei Wang, Xuemei Liu, Dexi Chen, Qinghua Meng" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Fang" "apellidos" => "Xie" ] 1 => array:2 [ "nombre" => "Jinling" "apellidos" => "Dong" ] 2 => array:2 [ "nombre" => "Yueke" "apellidos" => "Zhu" ] 3 => array:2 [ "nombre" => "Kefei" "apellidos" => "Wang" ] 4 => array:2 [ "nombre" => "Xuemei" "apellidos" => "Liu" ] 5 => array:2 [ "nombre" => "Dexi" "apellidos" => "Chen" ] 6 => array:2 [ "nombre" => "Qinghua" "apellidos" => "Meng" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119300730?idApp=UINPBA00004N" "url" => "/16652681/0000001800000005/v2_201909050846/S1665268119300730/v2_201909050846/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "“Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?”" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "765" "paginaFinal" => "769" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Daniel S. García, Etel I. Saturansky, Daniel Poncino, Yamila Martínez-Artola, Silvia Rosenberg, Gloria Abritta, Carlos Ascimani-Peña, Amerys Cravero" "autores" => array:8 [ 0 => array:4 [ "nombre" => "Daniel S." "apellidos" => "García" "email" => array:1 [ 0 => "dsgarcia@intramed.net" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Etel I." "apellidos" => "Saturansky" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Daniel" "apellidos" => "Poncino" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Yamila" "apellidos" => "Martínez-Artola" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "Silvia" "apellidos" => "Rosenberg" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 5 => array:3 [ "nombre" => "Gloria" "apellidos" => "Abritta" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 6 => array:3 [ "nombre" => "Carlos" "apellidos" => "Ascimani-Peña" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 7 => array:3 [ "nombre" => "Amerys" "apellidos" => "Cravero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Department of Hepatology, Sanatorio “Dr. Julio Méndez”, Ciudad Autónoma de Buenos Aires, Argentina" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Rheumatology, Sanatorio “Dr. Julio Méndez”, Ciudad Autónoma de Buenos Aires, Argentina" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Pathology, Sanatorio “Dr. Julio Méndez”, Ciudad Autónoma de Buenos Aires, Argentina" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author at: Department of Hepatology, Sanatorio Dr. Julio Méndez, Ob.S.B.A. Avellaneda 551, C1405CNF, Ciudad Autónoma de Buenos Aires, Argentina." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1955 "Ancho" => 3167 "Tamanyo" => 919019 ] ] "descripcion" => array:1 [ "en" => "Liver histological features." ] ] ] "textoCompleto" => "1IntroductionMethotrexate (MTX) is a folic acid analog with anti-proliferative, immunosuppressive and anti-inflammatory activity used in the treatment of arthritis since 1951 <a class="elsevierStyleCrossRef" href="#bib0185">[1]</a>. At present, one of the most common indications of MTX is the management of rheumatoid arthritis (RA) and psoriatic arthritis (PsA). MTX has modified the natural history with significant improvement of quality of life of these patients <a class="elsevierStyleCrossRefs" href="#bib0190">[2–5]</a>.Hepatotoxicity caused by MTX is second in frequency to gastrointestinal adverse effects <a class="elsevierStyleCrossRef" href="#bib0210">[6]</a>. With the use of single weekly low doses and the co-administration of folic acid, the frequency and severity of hepatotoxicity is reduced without loss of anti-inflammatory therapeutic effect <a class="elsevierStyleCrossRefs" href="#bib0215">[7–9]</a>.A recent systematic review <a class="elsevierStyleCrossRef" href="#bib0230">[10]</a> of MTX-induced liver toxicity of 18 studies with a weekly mean dose of 12.5mg included 2199 patients. The cumulative incidence of elevated liver transaminases was 49%. However, only 24% received folic acid and 56% concomitantly received non-steroidal anti-inflammatory drugs (NSAIDs). Due to enzyme elevation, MTX was reduced or suspended in 26% and permanently discontinued in 7%. In thirty-three other studies, also included in this review, liver histology was analyzed in 2179 patients with an average total cumulative dosage (TCD) of 2.4g showing mild fibrosis in 15.3%, moderate to severe fibrosis in 1.3% and cirrhosis in 0.5%. In pre-treatment liver biopsy from 372 patients, fibrosis was present in 9.1% and cirrhosis in 0.3%. Only 9% received folic acid supplement. Worth mention is the fact that, in most studies, risk factors for pre-existing liver disease such as alcohol use, obesity and diabetes were insufficiently reported. Therefore, in most of the studies analyzed, one of the most important criteria to attribute hepatic injury to a given drug was not met, which is to rule out other associated causes that may provoke it <a class="elsevierStyleCrossRef" href="#bib0235">[11]</a>.This shortfall spiked the interest to study the hepatotoxicity by MTX, using the current diagnostic methodology of drug induced liver injury (DILI). The objective of this study is to describe the frequency and characteristics of DILI by MTX in patients with RA and PsA with long-term MTX therapy, combined with folic acid in patients seen in a Rheumatology department in Buenos Aires.2Materials and methodsBetween December 2011 and September 2014, we included consecutive 18 years or older patients with diagnosis of RA (according to ACR/EULAR 2010 criteria <a class="elsevierStyleCrossRef" href="#bib0240">[12]</a>) or PsA (according to CASPAR criteria <a class="elsevierStyleCrossRef" href="#bib0245">[13]</a>) seen in the Rheumatology Department and receiving continuous weekly MTX treatment (oral or parenteral) up to 25mg, combined with folic acid. Patients with neoplasia or any condition with an expected survival under one year, those who could not comply with follow-up, who had not completed the initial evaluation, patients with Hepatitis B, Hepatitis C, HIV infection or autoimmune liver disease were excluded. This observational study was approved by the institutional review board and conformed to the ethical guidelines of the 2013 Declaration of Helsinki. All participants gave written consent.Serial follow-up was carried out by hepatologists in order to determine the presence of MTX-induced hepatotoxicity. The initial evaluation consisted of a clinical history with anamnesis, physical exam, biochemical work-up and abdominal ultrasound. History of previous alcohol use, type, dose and duration of drug consumption, the TCD of MTX, non-alcoholic fatty liver disease associated factors (NAFLD) <a class="elsevierStyleCrossRef" href="#bib0250">[14]</a> such as obesity, diabetes, dyslipidemias and metabolic syndrome (according to the ALAD Consensus <a class="elsevierStyleCrossRef" href="#bib0255">[15]</a>) were recorded.The diagnosis of liver steatosis was based on abdominal ultrasound and defined as: (1) presence of diffuse hyperechoic echotexture (bright liver), (2) increase of liver echogenicity compared with the kidneys, (3) vascular blurring, and (4) deep attenuation <a class="elsevierStyleCrossRef" href="#bib0260">[16]</a>.In the initial evaluation as in follow-up, alanine aminotransferase (ALT)/aspartate aminotransferase (AST) determinations as markers of MTX toxicity were measured. Increases of these enzymes over 1.5 times upper limit of normal (ULN) were assessed with the Roussel Uclaf Causality Assessment Method (RUCAM) model <a class="elsevierStyleCrossRefs" href="#bib0265">[17,18]</a> in order to determine the presence or absence of toxicity by MTX or by other drugs. This system was specifically designed to determine the probability of a given drug developing liver toxicity based on: (1) the time relation between the administration of the drug and the onset of liver abnormalities; (2) the lapse to normalization after suspension; (3) the presence of risk factors such as alcohol consumption and age >55 years; (4) the consideration of other potential causes of enzyme alteration such as other drugs or concomitant liver disease and (5) behavior of the enzymes in case of re-exposure to the drug. A score of 0 or less rules out relation to the drug, 1–2 is improbable, 3–5 is possible, 6–8 is probable and >8 is highly probable.Liver biopsy (with additional prior informed consent) was proposed to the patients who had a MTX TCD≥3.5g or concurrent liver disease or sustained hepatic enzyme abnormalities, according to the recommendations of MTX management <a class="elsevierStyleCrossRefs" href="#bib0275">[19–21]</a>. The histological study was done with hematoxylin and eosin and Masson's trichrome stain. The histological scoring system of Kleiner et al. <a class="elsevierStyleCrossRef" href="#bib0290">[22]</a> was used considering it as the best adapted to alterations historically attributed to MTX <a class="elsevierStyleCrossRefs" href="#bib0295">[23–26]</a>. It assesses histological findings such as hepatocellular ballooning, steatosis, lobular inflammation, hepatocellular injury and characteristics of fibrosis. Steatosis is divided into 4 grades according to the percentage of hepatocytes with fat vacuoles: Grade 0 or absent (<5%), 1 or mild (5–33%), 2 or moderate (>33–66%) and 3 or severe (>66%). The lobular inflammation is classified, according to the presence of foci of 2 or more inflammatory cells, into: Grade 0 or absent (no foci), 1 or mild (<2 foci per 200× field), 2 or moderate (2–4 foci per 200× field) and 3 or severe (>4 foci per 200× field). Fibrosis is divided into stages: Stage 1: perisinusoidal or periportal (1a: mild, perisinusoidal, zone 3; 1b: moderate, perisinusoidal, zone 3 and 1c: periportal or portal); Stage 2: perisinusoidal and periportal without bridges of fibrosis; Stage 3: presence of bridging fibrosis and Stage 4: cirrhosis.2.1Statistical analysisQuantitative variables are expressed as mean±standard deviation if were normally distributed. Otherwise, they are presented as median and range. Qualitative results are expressed as percentages. The incidence rate of AST/ALT elevations was calculated considering the risk time from the baseline determination to the first elevation or to the last follow-up in cases with no liver enzyme elevation.3ResultsA total of 43 patients were enrolled in this study. Clinical and biochemical features are shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>At baseline, 1 case (2.3%) which presented elevation of ALT/AST was classified as probable DILI caused by celecoxib (RUCAM score=8).The follow-up of the 43 patients had a median of 32 (range: 1–48) months, and 3.3±1.7 biochemical tests – including liver enzymes – per year were performed. During this follow-up, 4 patients (9.3%) presented ALT/AST elevations (incidence rate: 3.9 cases per 100 persons-year). In 2 cases, the ALT/AST elevations were attributed to NSAIDs, 1 to meloxicam (RUCAM 7=probable) and 1 to the association of ibuprofen and diclofenac (RUCAM 7=probable). The remaining 2 cases met all criteria for NAFLD. Both presented steatosis on liver imaging and metabolic syndrome associated to fluctuating ALT/AST elevations which did not exceed 4 times ULN, in absence of a history of alcohol consumption.In the 5 cases with ALT/AST elevations, the RUCAM for MTX score did not exceed 2 (Improbable).Five patients consented to undergo liver biopsy. At the moment of biopsy, they presented a TCD for MTX between 3.5 and 7.4g (median 5.1) with no steatosis on ultrasound and no history of alcohol use. The histological findings can be seen in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>.<elsevierMultimedia ident="fig0005"></elsevierMultimedia>Two patients (Case 1 and Case 2) with TCD MTX of 4.2 and 4.7g respectively presented neither fibrosis nor steatosis. They presented only some non-specific cellular changes which did not correspond to any particular entity. These patients had no risk factors for liver disease.One patient (Case 3) on corticosteroid therapy and who had a 5 month history of ALT/AST elevation attributed to celecoxib (mentioned previously) with a TCD MTX of 3.5g presented a histological study showing mild portal, perisinusoidal and perivenular fibrosis (Kleiner's Score Fibrosis 2) without bridging, steatosis, inflammation, hepatocellular ballooning or other changes that imply NAFLD or other entity.Another patient (Case 4) with a TCD for MTX of 5.6g presented mild portal and perivenular fibrosis (Kleiner's Score Fibrosis 1c) and no other changes. After biopsy, this patient presented liver injury due to meloxicam (aforementioned).The last case (Case 5), who had a TCD for MTX of 7.4g presented 5% steatosis and mild portal fibrosis (Kleiner's Score Fibrosis 1c). The patient was borderline according to the definition of NAFLD and had no histological findings of steatohepatitis. The patient presented central obesity with a normal body mass index and signs of muscle wasting associated to limited mobility due to RA.4DiscussionMany studies have assessed MTX hepatotoxicity but few have applied diagnostic criteria for drug related causality. To our knowledge, this is the only study to have carried out a systematic evaluation of DILI in patients with chronic low-dose methotrexate and folic acid therapy. In clinical practice, diagnosis of DILI commonly implies a challenge since there is no specific diagnostic test <a class="elsevierStyleCrossRef" href="#bib0315">[27]</a>. Several score assessment methods have been developed. Currently, RUCAM scale, used in our study, is the most widely employed and recommended by experts. This method assesses the timing of onset of the adverse event in relation to starting the medication (challenge), and the timing of resolution in relation to stopping the medication (de-challenge), clinical features, specific risk factors, the exclusion of other transaminase-elevating conditions and the behavior after re exposure (re-challenge) if present. Points are awarded for each element and a final score confers the probability of a given drug's implication in causality of liver injury <a class="elsevierStyleCrossRef" href="#bib0320">[28]</a>.A relevant aspect which strengthens the applicability of these methods is the determination of other drugs with potential hepatotoxicity when combined with MTX. In a recent cross-sectional study <a class="elsevierStyleCrossRef" href="#bib0325">[29]</a> carried out in Buenos Aires on a series of 103 patients with RA and 15 with PsA (51% received MTX), the Maria and Victorino <a class="elsevierStyleCrossRef" href="#bib0330">[30]</a> system was applied to assess DILI. In 15 cases (12.5%), all liver injury was attributed to NSAID use, mainly diclofenac. In patients with RA and PsA on multiple drug treatment, singling out which drug is implied in hepatotoxicity requires a step-by-step method to determine the responsible agent <a class="elsevierStyleCrossRefs" href="#bib0235">[11,27]</a>.In the present study, carried out on 43 patients with a median follow-up greater than 2.5 years, no MTX hepatotoxicity was detected using the diagnostic methodology mentioned. The ALT/AST elevations were attributed to NSAIDs in 3 cases (6.9%) and to NAFLD in 2 cases (4.6%). On occasion, it can be thought that the ALT/AST elevations detected in some studies and in clinical practice have no relation to MTX. An erroneous etiological interpretation may lead to the discontinuation or definitive suspension of MTX, an effective, easily administered, low-cost drug and its replacement with alternative drugs such as costly biological agents with serious adverse effects. Some guidelines recommend contraindication or suspension of MTX according to the different levels or persistence of ALT/AST elevations without a diagnostic algorithm or an expert opinion to assess whether MTX was the probable cause of hepatotoxicity <a class="elsevierStyleCrossRefs" href="#bib0190">[2,19–21,31–33]</a>.The changes attributed to MTX in liver histology are indistinguishable from those caused by other entities such as alcohol-induced liver disease, NAFLD and secondary hepatic steatosis <a class="elsevierStyleCrossRef" href="#bib0310">[26]</a>. In presence of other entities which potentially induce liver injury, it is difficult to claim MTX as the cause of the histological findings. Moreover, most studies which include histological assessment apply classifications which consider the type of fibrosis observed in chronic viral hepatitis which elicit fibrosis starting at the portal space and, from there, spreading to the remaining parenchyma <a class="elsevierStyleCrossRefs" href="#bib0350">[34,35]</a>. Hence, the perisinusoidal NAFLD-like characteristics of presumptive MTX fibrosis are not adequately assessed. We chose Kleiner's classification <a class="elsevierStyleCrossRef" href="#bib0290">[22]</a> given its greater precision to assess changes attributable to MTX as well as other associated conditions commonly seen in patients with RA <a class="elsevierStyleCrossRef" href="#bib0360">[36]</a>. In the present study, no significant histological liver toxicity was found. In 5 patients with TCD (equivalent for time of exposure to injury) greater or equal to 3.5g of MTX and with no other evident cause of liver disease, no significant histological changes were found after years of treatment, including one case of 12 year-long treatment.The low percentage of ALT/AST elevations compared to those observed in other studies included in the systematic review by Visser and van der Heijde <a class="elsevierStyleCrossRef" href="#bib0230">[10]</a> might be explained by the low frequency of alcohol consumption and obesity in the sample and the use of folic acid among all our patients.In this small series, no biochemical or significant histological liver toxicity for MTX was demonstrated when applying causality criteria for DILI. There is no decisive evidence indicating MTX hepatotoxicity, especially when associated with folic acid and in weekly doses no greater than 25mg, commonly used in treatment of RA, PsA and inflammatory intestinal diseases. Further studies with larger population samples using DILI diagnostic methodology and the inclusion of experts trained in liver disease are needed to enhance knowledge of the causality or absence of MTX hepatotoxicity.AbbreviationsMTXmethotrexateRArheumatoid arthritisPsApsoriatic arthritisDILIdrug induced liver injuryALTalanine aminotransferaseASTaspartate aminotransferaseNAFLDnon-alcoholic fatty liver diseaseTCDtotal cumulative dosageRUCAMRoussel Uclaf Causality Assessment MethodNSAIDsnon-steroidal anti-inflammatory drugsULNupper limit of normalGrants and financial supportNothing to disclose.Conflicts of interestNone." "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres1239178" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1150038" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:3 [ "identificador" => "sec0010" "titulo" => "Materials and methods" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Statistical analysis" ] ] ] 4 => array:2 [ "identificador" => "sec0020" "titulo" => "Results" ] 5 => array:2 [ "identificador" => "sec0025" "titulo" => "Discussion" ] 6 => array:2 [ "identificador" => "sec0030" "titulo" => "Abbreviations" ] 7 => array:2 [ "identificador" => "sec0035" "titulo" => "Grants and financial support" ] 8 => array:2 [ "identificador" => "sec0040" "titulo" => "Conflicts of interest" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2018-11-27" "fechaAceptado" => "2019-01-31" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1150038" "palabras" => array:5 [ 0 => "Methotrexate" 1 => "Drug-induced liver injury" 2 => "Hepatotoxicity" 3 => "Rheumatoid arthritis" 4 => "Psoriatic arthritis" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "Introduction and ObjectivesLiver injury caused by methotrexate (MTX) has mostly been investigated without applying criteria for the assessment of causality of drug induced liver injury (DILI). Hence, the existence of DILI by MTX in many cases is debatable. This study aimed to describe the frequency and characteristics of liver injury caused by MTX, applying DILI diagnostic criteria. Material and methodsRheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients who were treated with MTX in association with folic acid were included. Serial determinations of alanine amino transferase (ALT) and aspartate amino transferase (AST) were performed. The Roussel Uclaf Causality Assessment Method (RUCAM) was applied in cases of increases of ALT/AST over 1.5 upper limit of normal. Liver biopsy was considered when the total cumulative dosage (TCD) of MTX was ≥3.5g. ResultsA total of 43 patients were analyzed (median follow up 32 (range: 1–48) months; 3.33 ALT/AST determinations per year). Five subjects presented an increase of ALT/AST. All presented a RUCAM score for MTX≤2 (improbable). Three had a RUCAM score for non-steroidal anti-inflammatory drugs ≥7 (probable) and two patients presented non-alcoholic fatty liver disease. Five patients with no other cause for liver disease consented to liver biopsy (TCD MTX: median 5.1; range: 3.5–7.4g). No significant fibrosis or steatosis was evident on histology. ConclusionsNo biochemical or significant histological liver toxicity for MTX was demonstrated when applying causality criteria for DILI. More studies with this methodology are necessary in order to improve the assessment of its frequency." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1955 "Ancho" => 3167 "Tamanyo" => 919019 ] ] "descripcion" => array:1 [ "en" => "Liver histological features." ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "SD: standard deviation. RA: rheumatoid arthritis. PsA: psoriatic arthritis. MTX: methotrexate. TCD: total cumulative dosage. NSAIDs: non-steroidal anti-inflammatory drug. BMI: body mass index. HDL: high-density lipoprotein. LDL: low-density lipoprotein." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">n=43 \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Age, yearsMean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">56±11 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Female, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">38 (88.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">RA, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">37 (86.0) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">PsA, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 (13.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MTX weekly dose (mg)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12.62±4.04 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MTX initial TCD (g)Media±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.76±2.28 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MTX final TCD (g)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4.3±2.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">NSAIDs, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">36 (83.7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Corticosteroids, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11 (25.5) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Biological agents, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">19 (44.1) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BMI (kg/m2)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">27.8±4.6 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BMI>25, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 (67.4) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">BMI>30, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11 (25.5) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Waist circumference (cm)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">93.7±10.2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Diabetes mellitus type 2, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 (9.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Arterial hypertension, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8 (18.6) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Total cholesterol (mg/dL)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">193.4±33.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HDL Cholesterol (mg/dL)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">55.6±14.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">LDL Cholesterol (mg/dL)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">112.6±31.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Triglycerides (mg/dL)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">129.3±55.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Metabolic syndrome, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 (27.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Alcohol intake >20g/day, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 (13.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Evolution time RA and PsA (months)Mean±SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">112±104 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Liver steatosis, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20 (46.5) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2117399.png" ] ] ] ] "descripcion" => array:1 [ "en" => "General features of patients enrolled." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:36 [ 0 => array:3 [ "identificador" => "bib0185" "etiqueta" => "[1]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-inflammatory mechanisms of methotrexate in rheumatoid Arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Cutolo" 1 => "A. Sulli" 2 => "C. Pizzorni" 3 => "Seriolo" 4 => "R.H. Straub" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2001" "volumen" => "60" "paginaInicial" => "729" "paginaFinal" => "735" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0190" "etiqueta" => "[2]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.A. Singh" 1 => "K.G. Saag" 2 => "S.L. Bridges Jr." 3 => "E.A. Akl" 4 => "R.R. Bannuru" 5 => "M.C. Sullivan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2016" "volumen" => "68" "paginaInicial" => "1" "paginaFinal" => "26" "itemHostRev" => array:3 [ "pii" => "S1885585718300239" "estado" => "S300" "issn" => "18855857" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0195" "etiqueta" => "[3]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methotrexate: a gold standard for treatment of rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.G. Shinde" 1 => "M.P. Venkatesh" 2 => "T.M. Pramod Kumar" 3 => "H.G. Shivakumar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pain Palliat Care Pharmacother" "fecha" => "2014" "volumen" => "28" "paginaInicial" => "351" "paginaFinal" => "358" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0200" "etiqueta" => "[4]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methotrexate for treating rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.A. Lopez-Olivo" 1 => "H.R. Siddhanamatha" 2 => "B. Shea" 3 => "P. Tuqwell" 4 => "G.A. Wells" 5 => "M.E. Suarez-Almazor" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2014" "numero" => "6" "paginaInicial" => "CD000957" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0205" "etiqueta" => "[5]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Gossec" 1 => "J.S. Smolen" 2 => "S. Ramiro" 3 => "M. de Wit" 4 => "M. Cutolo" 5 => "M. Dougados" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2016" "volumen" => "75" "paginaInicial" => "499" "paginaFinal" => "510" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0210" "etiqueta" => "[6]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk and management of liver toxicity during methotrexate treatment in rheumatoid arthritis patients: a systematic literature research" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Salliot" 1 => "D. van der Heijde" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2009" "volumen" => "68" "paginaInicial" => "1100" "paginaFinal" => "1104" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0215" "etiqueta" => "[7]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methotrexate hepatotoxicity psoriasis – comparison of different dose regimens" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.G. Dahl" 1 => "M.M. Gregory" 2 => "P.J. Scheuer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br Med J" "fecha" => "1972" "volumen" => "1" "paginaInicial" => "654" "paginaFinal" => "656" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0220" "etiqueta" => "[8]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.E. van Ede" 1 => "R.F. Laan" 2 => "M.J. Rood" 3 => "T.W. Huizinga" 4 => "M.A. van de Laar" 5 => "C.J. van Denderen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2001" "volumen" => "44" "paginaInicial" => "1515" "paginaFinal" => "1524" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0225" "etiqueta" => "[9]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.L. Whittle" 1 => "R.A. Hughes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheumatology" "fecha" => "2004" "volumen" => "43" "paginaInicial" => "267" "paginaFinal" => "271" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0230" "etiqueta" => "[10]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Visser" 1 => "D. van der Heijde" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Exp Rheumatol" "fecha" => "2009" "volumen" => "27" "paginaInicial" => "1017" "paginaFinal" => "1025" "itemHostRev" => array:3 [ "pii" => "S073510970401719X" "estado" => "S300" "issn" => "07351097" ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0235" "etiqueta" => "[11]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Practical guidelines for diagnosis and early management of drug-induced liver injury" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Tajiri" 1 => "Y. Shimizu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2008" "volumen" => "14" "paginaInicial" => "6774" "paginaFinal" => "6785" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0240" "etiqueta" => "[12]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Aletaha" 1 => "T. Neogi" 2 => "A.J. Silman" 3 => "J. Funovits" 4 => "D.T. Felson" 5 => "C.O. Bingham 3rd" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2010" "volumen" => "69" "paginaInicial" => "1580" "paginaFinal" => "1588" "itemHostRev" => array:3 [ "pii" => "S1885585716304595" "estado" => "S300" "issn" => "18855857" ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0245" "etiqueta" => "[13]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Classification criteria for psoriatic arthritis. Development of new criteria from a large international study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W. Taylor" 1 => "D. Gladman" 2 => "P. Helliwell" 3 => "A. Marchesoni" 4 => "P. Mease" 5 => "H. Mielants" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arthrit Rheum" "fecha" => "2006" "volumen" => "54" "paginaInicial" => "2665" "paginaFinal" => "2673" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0250" "etiqueta" => "[14]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A position statement on NAFLD/NASH based on the EASL 2009 special conference" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "V. Ratziu" 1 => "S. Bellentani" 2 => "H. Cortez-Pinto" 3 => "C. Day" 4 => "G. Marchesini" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Hepatol" "fecha" => "2010" "volumen" => "53" "paginaInicial" => "372" "paginaFinal" => "384" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0255" "etiqueta" => "[15]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiología, Diagnóstico, Control, Prevención y Tratamiento del Síndrome Metabólico en Adultos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Consenso Latinoamericano de la Asociación Latinoamericana de Diabetes (ALAD)" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Revista ALAD" "fecha" => "2010" "volumen" => "13" "paginaInicial" => "25" "paginaFinal" => "44" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "http://www.revistaalad.com/files/100125-44.pdf" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0260" "etiqueta" => "[16]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "AGA technical review on nonalcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A.J. Sanyal" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gastroenterology" "fecha" => "2002" "volumen" => "123" "paginaInicial" => "1705" "paginaFinal" => "1725" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0265" "etiqueta" => "[17]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Danan" 1 => "C. Bénichou" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Epidemiol" "fecha" => "1993" "volumen" => "46" "paginaInicial" => "1323" "paginaFinal" => "1330" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0270" "etiqueta" => "[18]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Bénichou" 1 => "G. Danan" 2 => "A. Flahault" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Epidemiol" "fecha" => "1993" "volumen" => "46" "paginaInicial" => "1331" "paginaFinal" => "1336" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0275" "etiqueta" => "[19]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methotrexate and Psoriasis: 2009 National Psoriasis Foundation Consensus Conference" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.E. Kalb" 1 => "B. Strober" 2 => "G. Weinstein" 3 => "M. Lebwohl" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2009" "volumen" => "60" "paginaInicial" => "824" "paginaFinal" => "837" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0280" "etiqueta" => "[20]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guías Argentinas de Práctica Clínica en el Tratamiento de la Artritis Reumatoidea" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Sociedad Argentina de Reumatología" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Argent Reumatol" "fecha" => "2008" "volumen" => "3" "paginaInicial" => "3" "paginaFinal" => "87" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0285" "etiqueta" => "[21]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Visser" 1 => "W. Katchamart" 2 => "E. Loza" 3 => "J.A. Martinez-Lopez" 4 => "C. Salliot" 5 => "J. Trudeau" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2009" "volumen" => "68" "paginaInicial" => "1086" "paginaFinal" => "1093" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0290" "etiqueta" => "[22]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.E. Kleiner" 1 => "E.M. Brunt" 2 => "M. Van Natta" 3 => "C. Behling" 4 => "M.J. Contos" 5 => "O.W. Cummings" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hepatology" "fecha" => "2005" "volumen" => "41" "paginaInicial" => "1313" "paginaFinal" => "1321" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0295" "etiqueta" => "[23]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver damage due to methotrexate in patients with psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.G. Dahl" 1 => "M.M. Gregory" 2 => "P.J. Scheuer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br Med J" "fecha" => "1971" "volumen" => "1" "paginaInicial" => "625" "paginaFinal" => "630" "itemHostRev" => array:3 [ "pii" => "S016752731732510X" "estado" => "S300" "issn" => "01675273" ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0300" "etiqueta" => "[24]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of methotrexate on the liver in psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L.T. Reese" 1 => "J.W. Grisham" 2 => "R.D. Aach" 3 => "A.Z. Eisen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "1974" "volumen" => "62" "paginaInicial" => "597" "paginaFinal" => "602" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0305" "etiqueta" => "[25]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E. Szanto" 1 => "B. Sandstedt" 2 => "B. Kollberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Scand J Rheumatol" "fecha" => "1987" "volumen" => "16" "paginaInicial" => "229" "paginaFinal" => "234" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0310" "etiqueta" => "[26]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Aponte" 1 => "M. Petrelli" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arthrit Rheum" "fecha" => "1988" "volumen" => "31" "paginaInicial" => "1457" "paginaFinal" => "1464" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0315" "etiqueta" => "[27]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R.J. Andrade" 1 => "M. Robles" 2 => "A. Fernández-Castañer" 3 => "S. Lopez-Ortega" 4 => "M.C. Lopez-Vega" 5 => "M.I. Lucena" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2007" "volumen" => "13" "paginaInicial" => "329" "paginaFinal" => "340" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0320" "etiqueta" => "[28]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.J. Fontana" 1 => "L.B. Seeff" 2 => "R.J. Andrade" 3 => "E. Bjornsson" 4 => "C.P. Day" 5 => "J. Serrano" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hepatology" "fecha" => "2010" "volumen" => "52" "paginaInicial" => "730" "paginaFinal" => "742" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0325" "etiqueta" => "[29]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enfermedades hepáticas en artritis reumatoidea y artritis psoriasica" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. García" 1 => "E. Saturansky" 2 => "D. Poncino" 3 => "V. Ortiz" 4 => "Y. Martinez-Artola" 5 => "S. Rosenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Acta Gastroent Latinoamer" "fecha" => "2012" "volumen" => "42" "paginaInicial" => "112" "paginaFinal" => "119" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0330" "etiqueta" => "[30]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "V.A. Maria" 1 => "R.M. Victorino" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hepatology" "fecha" => "1997" "volumen" => "26" "paginaInicial" => "664" "paginaFinal" => "669" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0335" "etiqueta" => "[31]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.G. Saag" 1 => "G.G. Teng" 2 => "N.M. Patkar" 3 => "J. Anuntiyo" 4 => "C. Finney" 5 => "J.R. Curtis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arthrit Rheum" "fecha" => "2008" "volumen" => "59" "paginaInicial" => "762" "paginaFinal" => "784" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0340" "etiqueta" => "[32]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.B. Warren" 1 => "S.C. Weatherhead" 2 => "C.H. Smith" 3 => "L.S. Exton" 4 => "M.F. Mohd Mustapa" 5 => "B. Kirby" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2016" "volumen" => "175" "paginaInicial" => "23" "paginaFinal" => "44" ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0345" "etiqueta" => "[33]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methotrexate use and monitoring in patients with psoriasis: a consensus report based on a Danish Expert Meeting" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Raaby" 1 => "C. Zachariae" 2 => "M. Østensen" 3 => "L. Heickendorff" 4 => "P. Thielsen" 5 => "H. Grønbæk" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2017" "volumen" => "97" "paginaInicial" => "426" "paginaFinal" => "432" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0350" "etiqueta" => "[34]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methotrexate guidelines: revised" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "H.H. Roenigk Jr." 1 => "R. Auerbach" 2 => "H.I. Mailbach" 3 => "G.D. Weinstein" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "1982" "volumen" => "38" "paginaInicial" => "478" "paginaFinal" => "485" ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0355" "etiqueta" => "[35]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.M. Kremer" 1 => "R.G. Lee" 2 => "K.G. Tolman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arthrit Rheum" "fecha" => "1989" "volumen" => "32" "paginaInicial" => "121" "paginaFinal" => "127" ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0360" "etiqueta" => "[36]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Rosenberg" 1 => "H. Urwitz" 2 => "A. Johannesson" 3 => "A.M. Ros" 4 => "J. Lindholm" 5 => "N. Kinnman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Hepatol" "fecha" => "2007" "volumen" => "46" "paginaInicial" => "1111" "paginaFinal" => "1118" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000001800000005/v2_201909050846/S1665268119300742/v2_201909050846/en/main.assets" "Apartado" => array:4 [ "identificador" => "78265" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000001800000005/v2_201909050846/S1665268119300742/v2_201909050846/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119300742?idApp=UINPBA00004N"]

Statistics

Original article

Daniel S. Garcíaa,

Corresponding author

dsgarcia@intramed.net

Corresponding author at: Department of Hepatology, Sanatorio Dr. Julio Méndez, Ob.S.B.A. Avellaneda 551, C1405CNF, Ciudad Autónoma de Buenos Aires, Argentina.

, Etel I. Saturanskyb, Daniel Poncinoa, Yamila Martínez-Artolaa, Silvia Rosenbergb, Gloria Abrittab, Carlos Ascimani-Peñab, Amerys Craveroc

a Department of Hepatology, Sanatorio “Dr. Julio Méndez”, Ciudad Autónoma de Buenos Aires, Argentina

b Department of Rheumatology, Sanatorio “Dr. Julio Méndez”, Ciudad Autónoma de Buenos Aires, Argentina

c Department of Pathology, Sanatorio “Dr. Julio Méndez”, Ciudad Autónoma de Buenos Aires, Argentina

Read

12514

Times
was read the article

1644

Total PDF

10870

Total HTML

Share statistics

 array:24 [
  "pii" => "S1665268119300742"
  "issn" => "16652681"
  "doi" => "10.1016/j.aohep.2019.01.011"
  "estado" => "S300"
  "fechaPublicacion" => "2019-09-01"
  "aid" => "66"
  "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
  "copyrightAnyo" => "2019"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Ann Hepatol. 2019;18:765-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 401
    "formatos" => array:3 [
      "EPUB" => 24
      "HTML" => 164
      "PDF" => 213
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1665268119300602"
    "issn" => "16652681"
    "doi" => "10.1016/j.aohep.2019.01.008"
    "estado" => "S300"
    "fechaPublicacion" => "2019-09-01"
    "aid" => "52"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Ann Hepatol. 2019;18:770-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 264
      "formatos" => array:3 [
        "EPUB" => 21
        "HTML" => 151
        "PDF" => 92
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original articles</span>"
      "titulo" => "Protective effects of mild hypothermia against hepatic injury in rats with acute liver failure"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "770"
          "paginaFinal" => "776"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Fig&#46; 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 2690
              "Ancho" => 2915
              "Tamanyo" => 784852
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Effects of mild hypothermia on HMGB1 levels in blood and hepatic tissues &#40;A&#41; and &#40;B&#41; serum HMGB1 levels determined by ELISA and mRNA levels of HMGB1 in hepatic tissues detected by RT-PCR&#46; &#40;C&#41; Agarose gel electrophoresis images of HMGB1 mRNA expression in hepatic tissue&#46; &#40;D&#41; Representative images of protein expression levels of HMGB1 in hepatic tissue&#44; detected by immunohistochemistry at 400&#215; magnification&#46; &#40;E&#41; Protein expression levels of HMGB1 in hepatic tissue&#44; indicated by immunohistochemistry staining scores&#46; &#946;-Actin was used as a control&#46; &#42;&#42;&#42;<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 vs&#46; CG&#59; &#42;&#42;<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;01 vs&#46; CG&#59; &#42;<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05 vs&#46; CG&#59; <span class="elsevierStyleSup">&#35;&#35;&#35;</span><span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001 vs&#46; NG&#59; <span class="elsevierStyleSup">&#35;&#35;</span><span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;01 vs&#46; NG&#59; <span class="elsevierStyleSup">&#35;</span><span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05 vs&#46; NG&#46; HMGB1&#44; high mobility group box 1&#59; ELISA&#44; enzyme-linked immunosorbent assay&#59; mRNA&#44; messenger ribonucleic acid&#59; RT-PCR&#44; reverse transcription-polymerase chain reaction&#59; CG&#44; control group&#59; NG&#44; normothermia group&#59; MHG&#44; mild hypothermia group&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ying Zhu, Tianxin Xiang, Dali Hu, Bairu Shi, Wenyuan Zhang, Shouhua Zhang, Xiaoping Wu"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "Ying"
              "apellidos" => "Zhu"
            ]
            1 => array:2 [
              "nombre" => "Tianxin"
              "apellidos" => "Xiang"
            ]
            2 => array:2 [
              "nombre" => "Dali"
              "apellidos" => "Hu"
            ]
            3 => array:2 [
              "nombre" => "Bairu"
              "apellidos" => "Shi"
            ]
            4 => array:2 [
              "nombre" => "Wenyuan"
              "apellidos" => "Zhang"
            ]
            5 => array:2 [
              "nombre" => "Shouhua"
              "apellidos" => "Zhang"
            ]
            6 => array:2 [
              "nombre" => "Xiaoping"
              "apellidos" => "Wu"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119300602?idApp=UINPBA00004N"
    "url" => "/16652681/0000001800000005/v2_201909050846/S1665268119300602/v2_201909050846/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1665268119300730"
    "issn" => "16652681"
    "doi" => "10.1016/j.aohep.2019.03.007"
    "estado" => "S300"
    "fechaPublicacion" => "2019-09-01"
    "aid" => "65"
    "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "pgl"
    "cita" => "Ann Hepatol. 2019;18:757-64"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 216
      "formatos" => array:3 [
        "EPUB" => 16
        "HTML" => 129
        "PDF" => 71
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "HIF1a Inhibitor Rescues Acute-on-Chronic Liver Failure"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "757"
          "paginaFinal" => "764"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 2087
              "Ancho" => 3015
              "Tamanyo" => 430733
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Effects of genistein on mitochondrial function and ROS production&#46;Mitochondrialwas isolated from rat hepatocytes&#46; Liver tissues were cut into pieces to obtain single cells using the single-cell suspension preparation equipment The suspension was centrifuged at 4000<span class="elsevierStyleHsp" style=""></span>g for 10<span class="elsevierStyleHsp" style=""></span>min at 4<span class="elsevierStyleHsp" style=""></span>&#176;C&#46; The single-cell precipitate was resuspended&#46; ROS fluorescent probe 2&#8217;&#44; 7&#8217;-dichlorofluorescin diacetate was added and fluorescence intensity of single cell suspension was measured at random using flow cytometry&#46; Different correspondence letters indicate significant differences at P&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05 by the Student t test&#46;&#42; p &#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#44; &#42;&#42; p &#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#46; ATP content in mitochondriain GroupI&#44; II&#44; III and IV&#46; &#40;B&#41; ADP&#47;O level in GroupI&#44; II&#44; III and IV&#46; &#40;C&#41;Mitochondrial respiratory control ratio &#40;RCR&#41; in GroupI&#44; II&#44; III and IV&#46; &#40;D&#41; The detection of MPTP opening in GroupI&#44; II&#44; III and IV&#46;&#40;E&#41; The ultrastructure of mitochondria in GroupI&#44; II&#44; III and IV&#46; &#40;F-J&#41;ROS level in GroupI&#44; II&#44; III&#44; IV and V &#40;K-M&#41; MTPT&#44; ATP content and RCR of mitochondrial in Group III&#44; IV and V&#46;&#40;N-P&#41; ATP content&#44; RCR and MTPT of mitochondrial in&#44; Group III&#44; IV and VI&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Fang Xie, Jinling Dong, Yueke Zhu, Kefei Wang, Xuemei Liu, Dexi Chen, Qinghua Meng"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "Fang"
              "apellidos" => "Xie"
            ]
            1 => array:2 [
              "nombre" => "Jinling"
              "apellidos" => "Dong"
            ]
            2 => array:2 [
              "nombre" => "Yueke"
              "apellidos" => "Zhu"
            ]
            3 => array:2 [
              "nombre" => "Kefei"
              "apellidos" => "Wang"
            ]
            4 => array:2 [
              "nombre" => "Xuemei"
              "apellidos" => "Liu"
            ]
            5 => array:2 [
              "nombre" => "Dexi"
              "apellidos" => "Chen"
            ]
            6 => array:2 [
              "nombre" => "Qinghua"
              "apellidos" => "Meng"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119300730?idApp=UINPBA00004N"
    "url" => "/16652681/0000001800000005/v2_201909050846/S1665268119300730/v2_201909050846/en/main.assets"
  ]
  "en" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
    "titulo" => "&#8220;Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis&#46; What is its real frequency&#63;&#8221;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "765"
        "paginaFinal" => "769"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Daniel S&#46; Garc&#237;a, Etel I&#46; Saturansky, Daniel Poncino, Yamila Mart&#237;nez-Artola, Silvia Rosenberg, Gloria Abritta, Carlos Ascimani-Pe&#241;a, Amerys Cravero"
        "autores" => array:8 [
          0 => array:4 [
            "nombre" => "Daniel S&#46;"
            "apellidos" => "Garc&#237;a"
            "email" => array:1 [
              0 => "dsgarcia@intramed.net"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Etel I&#46;"
            "apellidos" => "Saturansky"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Daniel"
            "apellidos" => "Poncino"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Yamila"
            "apellidos" => "Mart&#237;nez-Artola"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Silvia"
            "apellidos" => "Rosenberg"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Gloria"
            "apellidos" => "Abritta"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Carlos"
            "apellidos" => "Ascimani-Pe&#241;a"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Amerys"
            "apellidos" => "Cravero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Department of Hepatology&#44; Sanatorio &#8220;Dr&#46; Julio M&#233;ndez&#8221;&#44; Ciudad Aut&#243;noma de Buenos Aires&#44; Argentina"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Department of Rheumatology&#44; Sanatorio &#8220;Dr&#46; Julio M&#233;ndez&#8221;&#44; Ciudad Aut&#243;noma de Buenos Aires&#44; Argentina"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Department of Pathology&#44; Sanatorio &#8220;Dr&#46; Julio M&#233;ndez&#8221;&#44; Ciudad Aut&#243;noma de Buenos Aires&#44; Argentina"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author at&#58; Department of Hepatology&#44; Sanatorio Dr&#46; Julio M&#233;ndez&#44; Ob&#46;S&#46;B&#46;A&#46; Avellaneda 551&#44; C1405CNF&#44; Ciudad Aut&#243;noma de Buenos Aires&#44; Argentina&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1955
            "Ancho" => 3167
            "Tamanyo" => 919019
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Liver histological features&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">1</span><span class="elsevierStyleSectionTitle" id="sect0035">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Methotrexate &#40;MTX&#41; is a folic acid analog with anti-proliferative&#44; immunosuppressive and anti-inflammatory activity used in the treatment of arthritis since 1951 <a class="elsevierStyleCrossRef" href="#bib0185">&#91;1&#93;</a>&#46; At present&#44; one of the most common indications of MTX is the management of rheumatoid arthritis &#40;RA&#41; and psoriatic arthritis &#40;PsA&#41;&#46; MTX has modified the natural history with significant improvement of quality of life of these patients <a class="elsevierStyleCrossRefs" href="#bib0190">&#91;2&#8211;5&#93;</a>&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Hepatotoxicity caused by MTX is second in frequency to gastrointestinal adverse effects <a class="elsevierStyleCrossRef" href="#bib0210">&#91;6&#93;</a>&#46; With the use of single weekly low doses and the co-administration of folic acid&#44; the frequency and severity of hepatotoxicity is reduced without loss of anti-inflammatory therapeutic effect <a class="elsevierStyleCrossRefs" href="#bib0215">&#91;7&#8211;9&#93;</a>&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">A recent systematic review <a class="elsevierStyleCrossRef" href="#bib0230">&#91;10&#93;</a> of MTX-induced liver toxicity of 18 studies with a weekly mean dose of 12&#46;5<span class="elsevierStyleHsp" style=""></span>mg included 2199 patients&#46; The cumulative incidence of elevated liver transaminases was 49&#37;&#46; However&#44; only 24&#37; received folic acid and 56&#37; concomitantly received non-steroidal anti-inflammatory drugs &#40;NSAIDs&#41;&#46; Due to enzyme elevation&#44; MTX was reduced or suspended in 26&#37; and permanently discontinued in 7&#37;&#46; In thirty-three other studies&#44; also included in this review&#44; liver histology was analyzed in 2179 patients with an average total cumulative dosage &#40;TCD&#41; of 2&#46;4<span class="elsevierStyleHsp" style=""></span>g showing mild fibrosis in 15&#46;3&#37;&#44; moderate to severe fibrosis in 1&#46;3&#37; and cirrhosis in 0&#46;5&#37;&#46; In pre-treatment liver biopsy from 372 patients&#44; fibrosis was present in 9&#46;1&#37; and cirrhosis in 0&#46;3&#37;&#46; Only 9&#37; received folic acid supplement&#46; Worth mention is the fact that&#44; in most studies&#44; risk factors for pre-existing liver disease such as alcohol use&#44; obesity and diabetes were insufficiently reported&#46; Therefore&#44; in most of the studies analyzed&#44; one of the most important criteria to attribute hepatic injury to a given drug was not met&#44; which is to rule out other associated causes that may provoke it <a class="elsevierStyleCrossRef" href="#bib0235">&#91;11&#93;</a>&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">This shortfall spiked the interest to study the hepatotoxicity by MTX&#44; using the current diagnostic methodology of drug induced liver injury &#40;DILI&#41;&#46; The objective of this study is to describe the frequency and characteristics of DILI by MTX in patients with RA and PsA with long-term MTX therapy&#44; combined with folic acid in patients seen in a Rheumatology department in Buenos Aires&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2</span><span class="elsevierStyleSectionTitle" id="sect0040">Materials and methods</span><p id="par0025" class="elsevierStylePara elsevierViewall">Between December 2011 and September 2014&#44; we included consecutive 18 years or older patients with diagnosis of RA &#40;according to ACR&#47;EULAR 2010 criteria <a class="elsevierStyleCrossRef" href="#bib0240">&#91;12&#93;</a>&#41; or PsA &#40;according to CASPAR criteria <a class="elsevierStyleCrossRef" href="#bib0245">&#91;13&#93;</a>&#41; seen in the Rheumatology Department and receiving continuous weekly MTX treatment &#40;oral or parenteral&#41; up to 25<span class="elsevierStyleHsp" style=""></span>mg&#44; combined with folic acid&#46; Patients with neoplasia or any condition with an expected survival under one year&#44; those who could not comply with follow-up&#44; who had not completed the initial evaluation&#44; patients with Hepatitis B&#44; Hepatitis C&#44; HIV infection or autoimmune liver disease were excluded&#46; This observational study was approved by the institutional review board and conformed to the ethical guidelines of the 2013 Declaration of Helsinki&#46; All participants gave written consent&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Serial follow-up was carried out by hepatologists in order to determine the presence of MTX-induced hepatotoxicity&#46; The initial evaluation consisted of a clinical history with anamnesis&#44; physical exam&#44; biochemical work-up and abdominal ultrasound&#46; History of previous alcohol use&#44; type&#44; dose and duration of drug consumption&#44; the TCD of MTX&#44; non-alcoholic fatty liver disease associated factors &#40;NAFLD&#41; <a class="elsevierStyleCrossRef" href="#bib0250">&#91;14&#93;</a> such as obesity&#44; diabetes&#44; dyslipidemias and metabolic syndrome &#40;according to the ALAD Consensus <a class="elsevierStyleCrossRef" href="#bib0255">&#91;15&#93;</a>&#41; were recorded&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">The diagnosis of liver steatosis was based on abdominal ultrasound and defined as&#58; &#40;1&#41; presence of diffuse hyperechoic echotexture &#40;bright liver&#41;&#44; &#40;2&#41; increase of liver echogenicity compared with the kidneys&#44; &#40;3&#41; vascular blurring&#44; and &#40;4&#41; deep attenuation <a class="elsevierStyleCrossRef" href="#bib0260">&#91;16&#93;</a>&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">In the initial evaluation as in follow-up&#44; alanine aminotransferase &#40;ALT&#41;&#47;aspartate aminotransferase &#40;AST&#41; determinations as markers of MTX toxicity were measured&#46; Increases of these enzymes over 1&#46;5 times upper limit of normal &#40;ULN&#41; were assessed with the Roussel Uclaf Causality Assessment Method &#40;RUCAM&#41; model <a class="elsevierStyleCrossRefs" href="#bib0265">&#91;17&#44;18&#93;</a> in order to determine the presence or absence of toxicity by MTX or by other drugs&#46; This system was specifically designed to determine the probability of a given drug developing liver toxicity based on&#58; &#40;1&#41; the time relation between the administration of the drug and the onset of liver abnormalities&#59; &#40;2&#41; the lapse to normalization after suspension&#59; &#40;3&#41; the presence of risk factors such as alcohol consumption and age &#62;55 years&#59; &#40;4&#41; the consideration of other potential causes of enzyme alteration such as other drugs or concomitant liver disease and &#40;5&#41; behavior of the enzymes in case of re-exposure to the drug&#46; A score of 0 or less rules out relation to the drug&#44; 1&#8211;2 is improbable&#44; 3&#8211;5 is possible&#44; 6&#8211;8 is probable and &#62;8 is highly probable&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Liver biopsy &#40;with additional prior informed consent&#41; was proposed to the patients who had a MTX TCD<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>3&#46;5<span class="elsevierStyleHsp" style=""></span>g or concurrent liver disease or sustained hepatic enzyme abnormalities&#44; according to the recommendations of MTX management <a class="elsevierStyleCrossRefs" href="#bib0275">&#91;19&#8211;21&#93;</a>&#46; The histological study was done with hematoxylin and eosin and Masson&#39;s trichrome stain&#46; The histological scoring system of Kleiner et al&#46; <a class="elsevierStyleCrossRef" href="#bib0290">&#91;22&#93;</a> was used considering it as the best adapted to alterations historically attributed to MTX <a class="elsevierStyleCrossRefs" href="#bib0295">&#91;23&#8211;26&#93;</a>&#46; It assesses histological findings such as hepatocellular ballooning&#44; steatosis&#44; lobular inflammation&#44; hepatocellular injury and characteristics of fibrosis&#46; Steatosis is divided into 4 grades according to the percentage of hepatocytes with fat vacuoles&#58; Grade 0 or absent &#40;&#60;5&#37;&#41;&#44; 1 or mild &#40;5&#8211;33&#37;&#41;&#44; 2 or moderate &#40;&#62;33&#8211;66&#37;&#41; and 3 or severe &#40;&#62;66&#37;&#41;&#46; The lobular inflammation is classified&#44; according to the presence of foci of 2 or more inflammatory cells&#44; into&#58; Grade 0 or absent &#40;no foci&#41;&#44; 1 or mild &#40;&#60;2 foci per 200&#215; field&#41;&#44; 2 or moderate &#40;2&#8211;4 foci per 200&#215; field&#41; and 3 or severe &#40;&#62;4 foci per 200&#215; field&#41;&#46; Fibrosis is divided into stages&#58; Stage 1&#58; perisinusoidal or periportal &#40;1a&#58; mild&#44; perisinusoidal&#44; zone 3&#59; 1b&#58; moderate&#44; perisinusoidal&#44; zone 3 and 1c&#58; periportal or portal&#41;&#59; Stage 2&#58; perisinusoidal and periportal without bridges of fibrosis&#59; Stage 3&#58; presence of bridging fibrosis and Stage 4&#58; cirrhosis&#46;</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;1</span><span class="elsevierStyleSectionTitle" id="sect0045">Statistical analysis</span><p id="par0050" class="elsevierStylePara elsevierViewall">Quantitative variables are expressed as mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>standard deviation if were normally distributed&#46; Otherwise&#44; they are presented as median and range&#46; Qualitative results are expressed as percentages&#46; The incidence rate of AST&#47;ALT elevations was calculated considering the risk time from the baseline determination to the first elevation or to the last follow-up in cases with no liver enzyme elevation&#46;</p></span></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3</span><span class="elsevierStyleSectionTitle" id="sect0050">Results</span><p id="par0055" class="elsevierStylePara elsevierViewall">A total of 43 patients were enrolled in this study&#46; Clinical and biochemical features are shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">At baseline&#44; 1 case &#40;2&#46;3&#37;&#41; which presented elevation of ALT&#47;AST was classified as probable DILI caused by celecoxib &#40;RUCAM score<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>8&#41;&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">The follow-up of the 43 patients had a median of 32 &#40;range&#58; 1&#8211;48&#41; months&#44; and 3&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;7 biochemical tests &#8211; including liver enzymes &#8211; per year were performed&#46; During this follow-up&#44; 4 patients &#40;9&#46;3&#37;&#41; presented ALT&#47;AST elevations &#40;incidence rate&#58; 3&#46;9 cases per 100 persons-year&#41;&#46; In 2 cases&#44; the ALT&#47;AST elevations were attributed to NSAIDs&#44; 1 to meloxicam &#40;RUCAM 7<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>probable&#41; and 1 to the association of ibuprofen and diclofenac &#40;RUCAM 7<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>probable&#41;&#46; The remaining 2 cases met all criteria for NAFLD&#46; Both presented steatosis on liver imaging and metabolic syndrome associated to fluctuating ALT&#47;AST elevations which did not exceed 4 times ULN&#44; in absence of a history of alcohol consumption&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">In the 5 cases with ALT&#47;AST elevations&#44; the RUCAM for MTX score did not exceed 2 &#40;Improbable&#41;&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Five patients consented to undergo liver biopsy&#46; At the moment of biopsy&#44; they presented a TCD for MTX between 3&#46;5 and 7&#46;4<span class="elsevierStyleHsp" style=""></span>g &#40;median 5&#46;1&#41; with no steatosis on ultrasound and no history of alcohol use&#46; The histological findings can be seen in <a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">Two patients &#40;Case 1 and Case 2&#41; with TCD MTX of 4&#46;2 and 4&#46;7<span class="elsevierStyleHsp" style=""></span>g respectively presented neither fibrosis nor steatosis&#46; They presented only some non-specific cellular changes which did not correspond to any particular entity&#46; These patients had no risk factors for liver disease&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">One patient &#40;Case 3&#41; on corticosteroid therapy and who had a 5 month history of ALT&#47;AST elevation attributed to celecoxib &#40;mentioned previously&#41; with a TCD MTX of 3&#46;5<span class="elsevierStyleHsp" style=""></span>g presented a histological study showing mild portal&#44; perisinusoidal and perivenular fibrosis &#40;Kleiner&#39;s Score Fibrosis 2&#41; without bridging&#44; steatosis&#44; inflammation&#44; hepatocellular ballooning or other changes that imply NAFLD or other entity&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">Another patient &#40;Case 4&#41; with a TCD for MTX of 5&#46;6<span class="elsevierStyleHsp" style=""></span>g presented mild portal and perivenular fibrosis &#40;Kleiner&#39;s Score Fibrosis 1c&#41; and no other changes&#46; After biopsy&#44; this patient presented liver injury due to meloxicam &#40;aforementioned&#41;&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">The last case &#40;Case 5&#41;&#44; who had a TCD for MTX of 7&#46;4<span class="elsevierStyleHsp" style=""></span>g presented 5&#37; steatosis and mild portal fibrosis &#40;Kleiner&#39;s Score Fibrosis 1c&#41;&#46; The patient was borderline according to the definition of NAFLD and had no histological findings of steatohepatitis&#46; The patient presented central obesity with a normal body mass index and signs of muscle wasting associated to limited mobility due to RA&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">4</span><span class="elsevierStyleSectionTitle" id="sect0055">Discussion</span><p id="par0100" class="elsevierStylePara elsevierViewall">Many studies have assessed MTX hepatotoxicity but few have applied diagnostic criteria for drug related causality&#46; To our knowledge&#44; this is the only study to have carried out a systematic evaluation of DILI in patients with chronic low-dose methotrexate and folic acid therapy&#46; In clinical practice&#44; diagnosis of DILI commonly implies a challenge since there is no specific diagnostic test <a class="elsevierStyleCrossRef" href="#bib0315">&#91;27&#93;</a>&#46; Several score assessment methods have been developed&#46; Currently&#44; RUCAM scale&#44; used in our study&#44; is the most widely employed and recommended by experts&#46; This method assesses the timing of onset of the adverse event in relation to starting the medication &#40;challenge&#41;&#44; and the timing of resolution in relation to stopping the medication &#40;de-challenge&#41;&#44; clinical features&#44; specific risk factors&#44; the exclusion of other transaminase-elevating conditions and the behavior after re exposure &#40;re-challenge&#41; if present&#46; Points are awarded for each element and a final score confers the probability of a given drug&#39;s implication in causality of liver injury <a class="elsevierStyleCrossRef" href="#bib0320">&#91;28&#93;</a>&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">A relevant aspect which strengthens the applicability of these methods is the determination of other drugs with potential hepatotoxicity when combined with MTX&#46; In a recent cross-sectional study <a class="elsevierStyleCrossRef" href="#bib0325">&#91;29&#93;</a> carried out in Buenos Aires on a series of 103 patients with RA and 15 with PsA &#40;51&#37; received MTX&#41;&#44; the Maria and Victorino <a class="elsevierStyleCrossRef" href="#bib0330">&#91;30&#93;</a> system was applied to assess DILI&#46; In 15 cases &#40;12&#46;5&#37;&#41;&#44; all liver injury was attributed to NSAID use&#44; mainly diclofenac&#46; In patients with RA and PsA on multiple drug treatment&#44; singling out which drug is implied in hepatotoxicity requires a step-by-step method to determine the responsible agent <a class="elsevierStyleCrossRefs" href="#bib0235">&#91;11&#44;27&#93;</a>&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">In the present study&#44; carried out on 43 patients with a median follow-up greater than 2&#46;5 years&#44; no MTX hepatotoxicity was detected using the diagnostic methodology mentioned&#46; The ALT&#47;AST elevations were attributed to NSAIDs in 3 cases &#40;6&#46;9&#37;&#41; and to NAFLD in 2 cases &#40;4&#46;6&#37;&#41;&#46; On occasion&#44; it can be thought that the ALT&#47;AST elevations detected in some studies and in clinical practice have no relation to MTX&#46; An erroneous etiological interpretation may lead to the discontinuation or definitive suspension of MTX&#44; an effective&#44; easily administered&#44; low-cost drug and its replacement with alternative drugs such as costly biological agents with serious adverse effects&#46; Some guidelines recommend contraindication or suspension of MTX according to the different levels or persistence of ALT&#47;AST elevations without a diagnostic algorithm or an expert opinion to assess whether MTX was the probable cause of hepatotoxicity <a class="elsevierStyleCrossRefs" href="#bib0190">&#91;2&#44;19&#8211;21&#44;31&#8211;33&#93;</a>&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">The changes attributed to MTX in liver histology are indistinguishable from those caused by other entities such as alcohol-induced liver disease&#44; NAFLD and secondary hepatic steatosis <a class="elsevierStyleCrossRef" href="#bib0310">&#91;26&#93;</a>&#46; In presence of other entities which potentially induce liver injury&#44; it is difficult to claim MTX as the cause of the histological findings&#46; Moreover&#44; most studies which include histological assessment apply classifications which consider the type of fibrosis observed in chronic viral hepatitis which elicit fibrosis starting at the portal space and&#44; from there&#44; spreading to the remaining parenchyma <a class="elsevierStyleCrossRefs" href="#bib0350">&#91;34&#44;35&#93;</a>&#46; Hence&#44; the perisinusoidal NAFLD-like characteristics of presumptive MTX fibrosis are not adequately assessed&#46; We chose Kleiner&#39;s classification <a class="elsevierStyleCrossRef" href="#bib0290">&#91;22&#93;</a> given its greater precision to assess changes attributable to MTX as well as other associated conditions commonly seen in patients with RA <a class="elsevierStyleCrossRef" href="#bib0360">&#91;36&#93;</a>&#46; In the present study&#44; no significant histological liver toxicity was found&#46; In 5 patients with TCD &#40;equivalent for time of exposure to injury&#41; greater or equal to 3&#46;5<span class="elsevierStyleHsp" style=""></span>g of MTX and with no other evident cause of liver disease&#44; no significant histological changes were found after years of treatment&#44; including one case of 12 year-long treatment&#46;</p><p id="par0120" class="elsevierStylePara elsevierViewall">The low percentage of ALT&#47;AST elevations compared to those observed in other studies included in the systematic review by Visser and van der Heijde <a class="elsevierStyleCrossRef" href="#bib0230">&#91;10&#93;</a> might be explained by the low frequency of alcohol consumption and obesity in the sample and the use of folic acid among all our patients&#46;</p><p id="par0125" class="elsevierStylePara elsevierViewall">In this small series&#44; no biochemical or significant histological liver toxicity for MTX was demonstrated when applying causality criteria for DILI&#46; There is no decisive evidence indicating MTX hepatotoxicity&#44; especially when associated with folic acid and in weekly doses no greater than 25<span class="elsevierStyleHsp" style=""></span>mg&#44; commonly used in treatment of RA&#44; PsA and inflammatory intestinal diseases&#46; Further studies with larger population samples using DILI diagnostic methodology and the inclusion of experts trained in liver disease are needed to enhance knowledge of the causality or absence of MTX hepatotoxicity&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Abbreviations</span><p id="par0130" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleDefList"><span class="elsevierStyleDefTerm">MTX</span><span class="elsevierStyleDefDescription"><p id="par0135" class="elsevierStylePara elsevierViewall">methotrexate</p></span><span class="elsevierStyleDefTerm">RA</span><span class="elsevierStyleDefDescription"><p id="par0140" class="elsevierStylePara elsevierViewall">rheumatoid arthritis</p></span><span class="elsevierStyleDefTerm">PsA</span><span class="elsevierStyleDefDescription"><p id="par0145" class="elsevierStylePara elsevierViewall">psoriatic arthritis</p></span><span class="elsevierStyleDefTerm">DILI</span><span class="elsevierStyleDefDescription"><p id="par0150" class="elsevierStylePara elsevierViewall">drug induced liver injury</p></span><span class="elsevierStyleDefTerm">ALT</span><span class="elsevierStyleDefDescription"><p id="par0155" class="elsevierStylePara elsevierViewall">alanine aminotransferase</p></span><span class="elsevierStyleDefTerm">AST</span><span class="elsevierStyleDefDescription"><p id="par0160" class="elsevierStylePara elsevierViewall">aspartate aminotransferase</p></span><span class="elsevierStyleDefTerm">NAFLD</span><span class="elsevierStyleDefDescription"><p id="par0165" class="elsevierStylePara elsevierViewall">non-alcoholic fatty liver disease</p></span><span class="elsevierStyleDefTerm">TCD</span><span class="elsevierStyleDefDescription"><p id="par0170" class="elsevierStylePara elsevierViewall">total cumulative dosage</p></span><span class="elsevierStyleDefTerm">RUCAM</span><span class="elsevierStyleDefDescription"><p id="par0175" class="elsevierStylePara elsevierViewall">Roussel Uclaf Causality Assessment Method</p></span><span class="elsevierStyleDefTerm">NSAIDs</span><span class="elsevierStyleDefDescription"><p id="par0180" class="elsevierStylePara elsevierViewall">non-steroidal anti-inflammatory drugs</p></span><span class="elsevierStyleDefTerm">ULN</span><span class="elsevierStyleDefDescription"><p id="par0185" class="elsevierStylePara elsevierViewall">upper limit of normal</p></span></span></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Grants and financial support</span><p id="par0190" class="elsevierStylePara elsevierViewall">Nothing to disclose&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Conflicts of interest</span><p id="par0195" class="elsevierStylePara elsevierViewall">None&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres1239178"
          "titulo" => "Abstract"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Introduction and Objectives"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Material and methods"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Results"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1150038"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        3 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Materials and methods"
          "secciones" => array:1 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Statistical analysis"
            ]
          ]
        ]
        4 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Results"
        ]
        5 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Discussion"
        ]
        6 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Abbreviations"
        ]
        7 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Grants and financial support"
        ]
        8 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Conflicts of interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2018-11-27"
    "fechaAceptado" => "2019-01-31"
    "PalabrasClave" => array:1 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1150038"
          "palabras" => array:5 [
            0 => "Methotrexate"
            1 => "Drug-induced liver injury"
            2 => "Hepatotoxicity"
            3 => "Rheumatoid arthritis"
            4 => "Psoriatic arthritis"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction and Objectives</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Liver injury caused by methotrexate &#40;MTX&#41; has mostly been investigated without applying criteria for the assessment of causality of drug induced liver injury &#40;DILI&#41;&#46; Hence&#44; the existence of DILI by MTX in many cases is debatable&#46; This study aimed to describe the frequency and characteristics of liver injury caused by MTX&#44; applying DILI diagnostic criteria&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Material and methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Rheumatoid arthritis &#40;RA&#41; and psoriatic arthritis &#40;PsA&#41; patients who were treated with MTX in association with folic acid were included&#46; Serial determinations of alanine amino transferase &#40;ALT&#41; and aspartate amino transferase &#40;AST&#41; were performed&#46; The Roussel Uclaf Causality Assessment Method &#40;RUCAM&#41; was applied in cases of increases of ALT&#47;AST over 1&#46;5 upper limit of normal&#46; Liver biopsy was considered when the total cumulative dosage &#40;TCD&#41; of MTX was &#8805;3&#46;5<span class="elsevierStyleHsp" style=""></span>g&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A total of 43 patients were analyzed &#40;median follow up 32 &#40;range&#58; 1&#8211;48&#41; months&#59; 3&#46;33 ALT&#47;AST determinations per year&#41;&#46; Five subjects presented an increase of ALT&#47;AST&#46; All presented a RUCAM score for MTX<span class="elsevierStyleHsp" style=""></span>&#8804;<span class="elsevierStyleHsp" style=""></span>2 &#40;improbable&#41;&#46; Three had a RUCAM score for non-steroidal anti-inflammatory drugs &#8805;7 &#40;probable&#41; and two patients presented non-alcoholic fatty liver disease&#46; Five patients with no other cause for liver disease consented to liver biopsy &#40;TCD MTX&#58; median 5&#46;1&#59; range&#58; 3&#46;5&#8211;7&#46;4<span class="elsevierStyleHsp" style=""></span>g&#41;&#46; No significant fibrosis or steatosis was evident on histology&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">No biochemical or significant histological liver toxicity for MTX was demonstrated when applying causality criteria for DILI&#46; More studies with this methodology are necessary in order to improve the assessment of its frequency&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Introduction and Objectives"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Material and methods"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Conclusions"
          ]
        ]
      ]
    ]
    "multimedia" => array:2 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1955
            "Ancho" => 3167
            "Tamanyo" => 919019
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Liver histological features&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">SD&#58; standard deviation&#46; RA&#58; rheumatoid arthritis&#46; PsA&#58; psoriatic arthritis&#46; MTX&#58; methotrexate&#46; TCD&#58; total cumulative dosage&#46; NSAIDs&#58; non-steroidal anti-inflammatory drug&#46; BMI&#58; body mass index&#46; HDL&#58; high-density lipoprotein&#46; LDL&#58; low-density lipoprotein&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>43&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Age&#44; yearsMean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">56<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Female&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">38 &#40;88&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">RA&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">37 &#40;86&#46;0&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">PsA&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 &#40;13&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">MTX weekly dose &#40;mg&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12&#46;62<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;04&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">MTX initial TCD &#40;g&#41;Media<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;76<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;28&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">MTX final TCD &#40;g&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">NSAIDs&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36 &#40;83&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Corticosteroids&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">11 &#40;25&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Biological agents&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19 &#40;44&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMI &#40;kg&#47;m<span class="elsevierStyleSup">2</span>&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">27&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMI<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>25&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">29 &#40;67&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMI<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>30&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">11 &#40;25&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Waist circumference &#40;cm&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">93&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#46;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Diabetes mellitus type 2&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4 &#40;9&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Arterial hypertension&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8 &#40;18&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Total cholesterol &#40;mg&#47;dL&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">193&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>33&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HDL Cholesterol &#40;mg&#47;dL&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">55&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>14&#46;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LDL Cholesterol &#40;mg&#47;dL&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">112&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>31&#46;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Triglycerides &#40;mg&#47;dL&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">129&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>55&#46;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Metabolic syndrome&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12 &#40;27&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Alcohol intake &#62;20<span class="elsevierStyleHsp" style=""></span>g&#47;day&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 &#40;13&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Evolution time RA and PsA &#40;months&#41;Mean<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">112<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>104&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Liver steatosis&#44; <span class="elsevierStyleItalic">n</span> &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">20 &#40;46&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2117399.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">General features of patients enrolled&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:36 [
            0 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "&#91;1&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-inflammatory mechanisms of methotrexate in rheumatoid Arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46; Cutolo"
                            1 => "A&#46; Sulli"
                            2 => "C&#46; Pizzorni"
                            3 => "Seriolo"
                            4 => "R&#46;H&#46; Straub"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2001"
                        "volumen" => "60"
                        "paginaInicial" => "729"
                        "paginaFinal" => "735"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "&#91;2&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;A&#46; Singh"
                            1 => "K&#46;G&#46; Saag"
                            2 => "S&#46;L&#46; Bridges Jr&#46;"
                            3 => "E&#46;A&#46; Akl"
                            4 => "R&#46;R&#46; Bannuru"
                            5 => "M&#46;C&#46; Sullivan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2016"
                        "volumen" => "68"
                        "paginaInicial" => "1"
                        "paginaFinal" => "26"
                        "itemHostRev" => array:3 [
                          "pii" => "S1885585718300239"
                          "estado" => "S300"
                          "issn" => "18855857"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "&#91;3&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methotrexate&#58; a gold standard for treatment of rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "C&#46;G&#46; Shinde"
                            1 => "M&#46;P&#46; Venkatesh"
                            2 => "T&#46;M&#46; Pramod Kumar"
                            3 => "H&#46;G&#46; Shivakumar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Pain Palliat Care Pharmacother"
                        "fecha" => "2014"
                        "volumen" => "28"
                        "paginaInicial" => "351"
                        "paginaFinal" => "358"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "&#91;4&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methotrexate for treating rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46;A&#46; Lopez-Olivo"
                            1 => "H&#46;R&#46; Siddhanamatha"
                            2 => "B&#46; Shea"
                            3 => "P&#46; Tuqwell"
                            4 => "G&#46;A&#46; Wells"
                            5 => "M&#46;E&#46; Suarez-Almazor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2014"
                        "numero" => "6"
                        "paginaInicial" => "CD000957"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "&#91;5&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "European League Against Rheumatism &#40;EULAR&#41; recommendations for the management of psoriatic arthritis with pharmacological therapies&#58; 2015 update"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Gossec"
                            1 => "J&#46;S&#46; Smolen"
                            2 => "S&#46; Ramiro"
                            3 => "M&#46; de Wit"
                            4 => "M&#46; Cutolo"
                            5 => "M&#46; Dougados"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2016"
                        "volumen" => "75"
                        "paginaInicial" => "499"
                        "paginaFinal" => "510"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "&#91;6&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk and management of liver toxicity during methotrexate treatment in rheumatoid arthritis patients&#58; a systematic literature research"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Salliot"
                            1 => "D&#46; van der Heijde"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2009"
                        "volumen" => "68"
                        "paginaInicial" => "1100"
                        "paginaFinal" => "1104"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "&#91;7&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methotrexate hepatotoxicity psoriasis &#8211; comparison of different dose regimens"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "M&#46;G&#46; Dahl"
                            1 => "M&#46;M&#46; Gregory"
                            2 => "P&#46;J&#46; Scheuer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Br Med J"
                        "fecha" => "1972"
                        "volumen" => "1"
                        "paginaInicial" => "654"
                        "paginaFinal" => "656"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "&#91;8&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis&#58; a forty-eight week&#44; multicenter&#44; randomized&#44; double-blind&#44; placebo-controlled study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;E&#46; van Ede"
                            1 => "R&#46;F&#46; Laan"
                            2 => "M&#46;J&#46; Rood"
                            3 => "T&#46;W&#46; Huizinga"
                            4 => "M&#46;A&#46; van de Laar"
                            5 => "C&#46;J&#46; van Denderen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2001"
                        "volumen" => "44"
                        "paginaInicial" => "1515"
                        "paginaFinal" => "1524"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "&#91;9&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Folate supplementation and methotrexate treatment in rheumatoid arthritis&#58; a review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S&#46;L&#46; Whittle"
                            1 => "R&#46;A&#46; Hughes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rheumatology"
                        "fecha" => "2004"
                        "volumen" => "43"
                        "paginaInicial" => "267"
                        "paginaFinal" => "271"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "&#91;10&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis&#58; a systematic review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "K&#46; Visser"
                            1 => "D&#46; van der Heijde"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Rheumatol"
                        "fecha" => "2009"
                        "volumen" => "27"
                        "paginaInicial" => "1017"
                        "paginaFinal" => "1025"
                        "itemHostRev" => array:3 [
                          "pii" => "S073510970401719X"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "&#91;11&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Practical guidelines for diagnosis and early management of drug-induced liver injury"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "K&#46; Tajiri"
                            1 => "Y&#46; Shimizu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "World J Gastroenterol"
                        "fecha" => "2008"
                        "volumen" => "14"
                        "paginaInicial" => "6774"
                        "paginaFinal" => "6785"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "&#91;12&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2010 rheumatoid arthritis classification criteria&#58; an American College of Rheumatology&#47;European League against rheumatism collaborative initiative"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Aletaha"
                            1 => "T&#46; Neogi"
                            2 => "A&#46;J&#46; Silman"
                            3 => "J&#46; Funovits"
                            4 => "D&#46;T&#46; Felson"
                            5 => "C&#46;O&#46; Bingham 3rd"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2010"
                        "volumen" => "69"
                        "paginaInicial" => "1580"
                        "paginaFinal" => "1588"
                        "itemHostRev" => array:3 [
                          "pii" => "S1885585716304595"
                          "estado" => "S300"
                          "issn" => "18855857"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "&#91;13&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Classification criteria for psoriatic arthritis&#46; Development of new criteria from a large international study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46; Taylor"
                            1 => "D&#46; Gladman"
                            2 => "P&#46; Helliwell"
                            3 => "A&#46; Marchesoni"
                            4 => "P&#46; Mease"
                            5 => "H&#46; Mielants"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthrit Rheum"
                        "fecha" => "2006"
                        "volumen" => "54"
                        "paginaInicial" => "2665"
                        "paginaFinal" => "2673"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "&#91;14&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A position statement on NAFLD&#47;NASH based on the EASL 2009 special conference"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "V&#46; Ratziu"
                            1 => "S&#46; Bellentani"
                            2 => "H&#46; Cortez-Pinto"
                            3 => "C&#46; Day"
                            4 => "G&#46; Marchesini"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "2010"
                        "volumen" => "53"
                        "paginaInicial" => "372"
                        "paginaFinal" => "384"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0255"
              "etiqueta" => "&#91;15&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiolog&#237;a&#44; Diagn&#243;stico&#44; Control&#44; Prevenci&#243;n y Tratamiento del S&#237;ndrome Metab&#243;lico en Adultos"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Consenso Latinoamericano de la Asociaci&#243;n Latinoamericana de Diabetes &#40;ALAD&#41;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:2 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Revista ALAD"
                        "fecha" => "2010"
                        "volumen" => "13"
                        "paginaInicial" => "25"
                        "paginaFinal" => "44"
                      ]
                    ]
                    1 => array:1 [
                      "WWW" => array:1 [
                        "link" => "http&#58;&#47;&#47;www&#46;revistaalad&#46;com&#47;files&#47;100125-44&#46;pdf"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "&#91;16&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "AGA technical review on nonalcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "A&#46;J&#46; Sanyal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2002"
                        "volumen" => "123"
                        "paginaInicial" => "1705"
                        "paginaFinal" => "1725"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "&#91;17&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Causality assessment of adverse reactions to drugs&#46; I&#46; A novel method based on the conclusions of international consensus meetings&#58; application to drug-induced liver injuries"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "G&#46; Danan"
                            1 => "C&#46; B&#233;nichou"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Clin Epidemiol"
                        "fecha" => "1993"
                        "volumen" => "46"
                        "paginaInicial" => "1323"
                        "paginaFinal" => "1330"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "&#91;18&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Causality assessment of adverse reactions to drugs&#8212;II&#46; An original model for validation of drug causality assessment methods&#58; case reports with positive rechallenge"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; B&#233;nichou"
                            1 => "G&#46; Danan"
                            2 => "A&#46; Flahault"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Clin Epidemiol"
                        "fecha" => "1993"
                        "volumen" => "46"
                        "paginaInicial" => "1331"
                        "paginaFinal" => "1336"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "&#91;19&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methotrexate and Psoriasis&#58; 2009 National Psoriasis Foundation Consensus Conference"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46;E&#46; Kalb"
                            1 => "B&#46; Strober"
                            2 => "G&#46; Weinstein"
                            3 => "M&#46; Lebwohl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2009"
                        "volumen" => "60"
                        "paginaInicial" => "824"
                        "paginaFinal" => "837"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "&#91;20&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gu&#237;as Argentinas de Pr&#225;ctica Cl&#237;nica en el Tratamiento de la Artritis Reumatoidea"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Sociedad Argentina de Reumatolog&#237;a"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rev Argent Reumatol"
                        "fecha" => "2008"
                        "volumen" => "3"
                        "paginaInicial" => "3"
                        "paginaFinal" => "87"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "&#91;21&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis&#58; integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46; Visser"
                            1 => "W&#46; Katchamart"
                            2 => "E&#46; Loza"
                            3 => "J&#46;A&#46; Martinez-Lopez"
                            4 => "C&#46; Salliot"
                            5 => "J&#46; Trudeau"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2009"
                        "volumen" => "68"
                        "paginaInicial" => "1086"
                        "paginaFinal" => "1093"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "&#91;22&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonalcoholic Steatohepatitis Clinical Research Network&#46; Design and validation of a histological scoring system for nonalcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46;E&#46; Kleiner"
                            1 => "E&#46;M&#46; Brunt"
                            2 => "M&#46; Van Natta"
                            3 => "C&#46; Behling"
                            4 => "M&#46;J&#46; Contos"
                            5 => "O&#46;W&#46; Cummings"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "2005"
                        "volumen" => "41"
                        "paginaInicial" => "1313"
                        "paginaFinal" => "1321"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "&#91;23&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Liver damage due to methotrexate in patients with psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "M&#46;G&#46; Dahl"
                            1 => "M&#46;M&#46; Gregory"
                            2 => "P&#46;J&#46; Scheuer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br Med J"
                        "fecha" => "1971"
                        "volumen" => "1"
                        "paginaInicial" => "625"
                        "paginaFinal" => "630"
                        "itemHostRev" => array:3 [
                          "pii" => "S016752731732510X"
                          "estado" => "S300"
                          "issn" => "01675273"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "&#91;24&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of methotrexate on the liver in psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "L&#46;T&#46; Reese"
                            1 => "J&#46;W&#46; Grisham"
                            2 => "R&#46;D&#46; Aach"
                            3 => "A&#46;Z&#46; Eisen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Invest Dermatol"
                        "fecha" => "1974"
                        "volumen" => "62"
                        "paginaInicial" => "597"
                        "paginaFinal" => "602"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0305"
              "etiqueta" => "&#91;25&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hepatotoxicity associated with low-dose&#44; long-term methotrexate treatment of rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "E&#46; Szanto"
                            1 => "B&#46; Sandstedt"
                            2 => "B&#46; Kollberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Scand J Rheumatol"
                        "fecha" => "1987"
                        "volumen" => "16"
                        "paginaInicial" => "229"
                        "paginaFinal" => "234"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0310"
              "etiqueta" => "&#91;26&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46; Aponte"
                            1 => "M&#46; Petrelli"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthrit Rheum"
                        "fecha" => "1988"
                        "volumen" => "31"
                        "paginaInicial" => "1457"
                        "paginaFinal" => "1464"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0315"
              "etiqueta" => "&#91;27&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Assessment of drug-induced hepatotoxicity in clinical practice&#58; a challenge for gastroenterologists"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "R&#46;J&#46; Andrade"
                            1 => "M&#46; Robles"
                            2 => "A&#46; Fern&#225;ndez-Casta&#241;er"
                            3 => "S&#46; Lopez-Ortega"
                            4 => "M&#46;C&#46; Lopez-Vega"
                            5 => "M&#46;I&#46; Lucena"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "World J Gastroenterol"
                        "fecha" => "2007"
                        "volumen" => "13"
                        "paginaInicial" => "329"
                        "paginaFinal" => "340"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0320"
              "etiqueta" => "&#91;28&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Standardization of nomenclature and causality assessment in drug-induced liver injury&#58; summary of a clinical research workshop"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;J&#46; Fontana"
                            1 => "L&#46;B&#46; Seeff"
                            2 => "R&#46;J&#46; Andrade"
                            3 => "E&#46; Bjornsson"
                            4 => "C&#46;P&#46; Day"
                            5 => "J&#46; Serrano"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "2010"
                        "volumen" => "52"
                        "paginaInicial" => "730"
                        "paginaFinal" => "742"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0325"
              "etiqueta" => "&#91;29&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Enfermedades hep&#225;ticas en artritis reumatoidea y artritis psoriasica"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Garc&#237;a"
                            1 => "E&#46; Saturansky"
                            2 => "D&#46; Poncino"
                            3 => "V&#46; Ortiz"
                            4 => "Y&#46; Martinez-Artola"
                            5 => "S&#46; Rosenberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Acta Gastroent Latinoamer"
                        "fecha" => "2012"
                        "volumen" => "42"
                        "paginaInicial" => "112"
                        "paginaFinal" => "119"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0330"
              "etiqueta" => "&#91;30&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "V&#46;A&#46; Maria"
                            1 => "R&#46;M&#46; Victorino"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "1997"
                        "volumen" => "26"
                        "paginaInicial" => "664"
                        "paginaFinal" => "669"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0335"
              "etiqueta" => "&#91;31&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;G&#46; Saag"
                            1 => "G&#46;G&#46; Teng"
                            2 => "N&#46;M&#46; Patkar"
                            3 => "J&#46; Anuntiyo"
                            4 => "C&#46; Finney"
                            5 => "J&#46;R&#46; Curtis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthrit Rheum"
                        "fecha" => "2008"
                        "volumen" => "59"
                        "paginaInicial" => "762"
                        "paginaFinal" => "784"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0340"
              "etiqueta" => "&#91;32&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "British Association of Dermatologists&#8217; guidelines for the safe and effective prescribing of methotrexate for skin disease 2016"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;B&#46; Warren"
                            1 => "S&#46;C&#46; Weatherhead"
                            2 => "C&#46;H&#46; Smith"
                            3 => "L&#46;S&#46; Exton"
                            4 => "M&#46;F&#46; Mohd Mustapa"
                            5 => "B&#46; Kirby"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2016"
                        "volumen" => "175"
                        "paginaInicial" => "23"
                        "paginaFinal" => "44"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0345"
              "etiqueta" => "&#91;33&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methotrexate use and monitoring in patients with psoriasis&#58; a consensus report based on a Danish Expert Meeting"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Raaby"
                            1 => "C&#46; Zachariae"
                            2 => "M&#46; &#216;stensen"
                            3 => "L&#46; Heickendorff"
                            4 => "P&#46; Thielsen"
                            5 => "H&#46; Gr&#248;nb&#230;k"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Acta Derm Venereol"
                        "fecha" => "2017"
                        "volumen" => "97"
                        "paginaInicial" => "426"
                        "paginaFinal" => "432"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0350"
              "etiqueta" => "&#91;34&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Methotrexate guidelines&#58; revised"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "H&#46;H&#46; Roenigk Jr&#46;"
                            1 => "R&#46; Auerbach"
                            2 => "H&#46;I&#46; Mailbach"
                            3 => "G&#46;D&#46; Weinstein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "1982"
                        "volumen" => "38"
                        "paginaInicial" => "478"
                        "paginaFinal" => "485"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0355"
              "etiqueta" => "&#91;35&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;M&#46; Kremer"
                            1 => "R&#46;G&#46; Lee"
                            2 => "K&#46;G&#46; Tolman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthrit Rheum"
                        "fecha" => "1989"
                        "volumen" => "32"
                        "paginaInicial" => "121"
                        "paginaFinal" => "127"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0360"
              "etiqueta" => "&#91;36&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Rosenberg"
                            1 => "H&#46; Urwitz"
                            2 => "A&#46; Johannesson"
                            3 => "A&#46;M&#46; Ros"
                            4 => "J&#46; Lindholm"
                            5 => "N&#46; Kinnman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "2007"
                        "volumen" => "46"
                        "paginaInicial" => "1111"
                        "paginaFinal" => "1118"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/16652681/0000001800000005/v2_201909050846/S1665268119300742/v2_201909050846/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "78265"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original Articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/16652681/0000001800000005/v2_201909050846/S1665268119300742/v2_201909050846/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119300742?idApp=UINPBA00004N"
]

Article information

ISSN: 16652681
Original language: English

DOI:10.1016/j.aohep.2019.01.011

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 October	271	10	281
2024 September	453	25	478
2024 August	412	36	448
2024 July	581	23	604
2024 June	359	32	391
2024 May	521	17	538
2024 April	477	35	512
2024 March	529	29	558
2024 February	515	41	556
2024 January	668	23	691
2023 December	511	20	531
2023 November	472	18	490
2023 October	527	17	544
2023 September	514	19	533
2023 August	398	19	417
2023 July	379	18	397
2023 June	321	20	341
2023 May	467	27	494
2023 April	257	10	267
2023 March	75	16	91
2023 February	69	9	78
2023 January	61	20	81
2022 December	55	14	69
2022 November	82	23	105
2022 October	85	20	105
2022 September	62	55	117
2022 August	59	66	125
2022 July	64	20	84
2022 June	41	13	54
2022 May	54	29	83
2022 April	67	27	94
2022 March	64	28	92
2022 February	36	19	55
2022 January	65	16	81
2021 December	34	17	51
2021 November	42	18	60
2021 October	48	23	71
2021 September	52	22	74
2021 August	45	17	62
2021 July	34	13	47
2021 June	58	20	78
2021 May	62	18	80
2021 April	155	41	196
2021 March	80	36	116
2021 February	47	40	87
2021 January	69	34	103
2020 December	58	52	110
2020 November	51	49	100
2020 October	42	20	62
2020 September	50	27	77
2020 August	33	28	61
2020 July	40	28	68
2020 June	35	20	55
2020 May	42	35	77
2020 April	13	22	35
2020 March	27	14	41
2020 February	35	44	79
2020 January	17	23	40
2019 December	12	36	48
2019 November	9	19	28
2019 October	29	24	53
2019 September	40	34	74
2019 August	6	9	15
2019 July	6	10	16
2019 June	18	14	32
2019 May	10	23	33

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter